Biohaven

6 hours ago
bookmarkBookmark

Biohaven is a company. It is in New Haven, the United States and its CEO is Vladimir Coric. It was founded in 2014 and is part of the Health Care sector, specifically in the Biotechnology industry.

Key facts

plus See more facts
link LinkedIn: 32K followers
link Instagram
link Facebook
link X (Twitter): 2K followers

Extract data

Download datasets about Biohaven:

dataset Dataset of stocks from Biohaven:

Biohaven is one of the companies in Biotechnology, companies in Health Care, companies in New Haven, companies in the United States and 3,456,835 companies in our database.

Talking Points

  • Clinicalstage Biopharmaceutical Company | Biohaven
  • Harnessing the boundless potential of scientific innovation to transform the treatment of neurological diseases.
  • Biohaven is a modern pharmaceutical company that is guided by science and inspired to change the lives of people with unmet medical needs.
  • Commercial-stage biopharmaceutical company with innovative drug candidates targeting neurological diseases. | Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. Biohaven obtained licenses from Yale University School of Medicine and Massachusetts General Hospital ...
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 for neuropsychiatric indications; and Verdiperstat, a product for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.
  • Discovery Research | Developing Bispecific Compounds and Innovative Therapies
  • Biohaven is developing drug candidates based on its proprietary, next-generation bispecific technology platforms and other innovative approaches.

Related

Connected or similar to Biohaven: .

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter.

This content is available under the CC BY 4.0 license.